Max Winokan is a computational chemist and advisor specializing in fragment-based lead discovery, currently shaping novel platform tools at Eli Lilly after leading antiviral fragment validation work at Diamond Light Source. With eight years of experience bridging academic and industry settings, he combines a PhD in computational chemistry/physics with hands-on software engineering skills gained at EA and in scientific visualization. He has collaborated with the University of Oxford’s Centre for Medicines Discovery and supervised graduate students, demonstrating both technical depth and mentorship. Comfortable across Python, C++ and GUI/tool development for scientific workflows, he brings a rare mix of drug discovery domain expertise and production-oriented engineering. An interesting through-line in his career is translating complex physical models into accessible visual and computational tools for both research and public audiences.
8 years of coding experience
1 year of employment as a software developer
MPhys Physics, MPhys Physics at University of Surrey
Contributions:232 commits, 182 pushes, 2 branches in 3 years 1 month
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.